Alle Studien
Aktiv, aber nicht rekrutierendPHASE2INTERVENTIONELL

Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation

This research study is looking for children aged 2 to 12 with sickle cell disease who have a healthy brother or sister who can donate bone marrow. The study aims to see how safe and effective a specific type of bone marrow transplant is for these children, including those with different levels of sickle cell disease. They will receive special medicines before the transplant to prepare their body. After the transplant, children will stay in hospital for a few weeks and then have close check-ups for about a year. The study hopes to understand the long-term effects of this treatment, such as how it affects their brain, kidneys, and overall well-being. The goal is to improve future care for children with sickle cell disease.

Auf einen Blick

Status
Aktiv, aber nicht rekrutierend
Phase
PHASE2
Sponsor
Emory University
Einschreibeziel
43
Starten
22 Mar 2019
Geschätzte Fertigstellung
01 Nov 2026

Worum geht es in dieser Studie?

This study is looking at a type of bone marrow transplant for young children with sickle cell disease. Bone marrow transplant involves replacing unhealthy blood-forming cells in a patient with healthy cells from a donor. In this study, the donor must be a healthy brother or sister who is a very good match for the patient.

Sickle cell disease can cause a lot of health problems, even for children who seem relatively well. This study is exploring if getting a bone marrow transplant at a younger age could prevent some of these serious problems as they get older. The doctors want to find out if this specific transplant method is safe and works well for children with different levels of sickle cell disease, including those who aren't severely affected yet.

The researchers will also be carefully tracking children for a long time after the transplant. They want to understand how this treatment affects important things like brain health, kidney function, and overall quality of life in the years following the transplant. This information will help doctors know if this treatment can lead to better health outcomes for children with sickle cell disease in the long run.

Wichtige Erkenntnisse

  • This study is for children aged 2-12 with sickle cell disease.
  • A healthy sibling (under 13) must be able to donate bone marrow.
  • It tests a specific type of bone marrow transplant.
  • The transplant involves special medicines and a hospital stay.
  • Long-term health and quality of life are being closely monitored.
  • The aim is to improve future treatment for sickle cell disease.

Wer könnte berechtigt sein?

This study is looking for children who are between 2 and 12 years old and have sickle cell disease. They also need to have a healthy brother or sister who is under 13 years old and a very close match for a bone marrow donation.

Your child's sickle cell disease needs to be causing some health problems. This could include things like having had a stroke, changes seen on brain scans, needing frequent hospital visits for pain, or having recurring chest problems. The study is open to children with both more severe and less severe forms of sickle cell disease.

Before taking part, your child and their potential sibling donor will have health checks to make sure they are suitable for the transplant.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Is your child between 2 and 12 years old?
  2. Does your child have sickle cell disease?
  3. Does your child have a healthy brother or sister who is under 13 and a very good bone marrow match?
  4. Has your child had any health issues related to their sickle cell disease (e.g., pain, stroke, chest problems)?
  5. Is your child healthy enough for a transplant, based on initial checks?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If your child qualifies for this study, they will have check-ups over 2 to 3 months to make sure they are healthy enough for the transplant. Once cleared, your child will go into the hospital. For about three weeks before the transplant, they will receive special medicines (including chemotherapy) to prepare their body to accept the donor cells.

After these preparations, your child will receive the bone marrow transplant. They will then stay in the hospital for another 4 to 6 weeks for close monitoring and recovery. Once they leave the hospital, they will have frequent appointments at the clinic for 6 to 12 months. After that, they will continue to have yearly check-ups for many years. The study will collect information about your child's health for two years after the transplant.

Potenzielle Risiken und Vorteile

Potential benefits could include stopping the progression of sickle cell disease symptoms and improving your child's long-term health and quality of life. However, bone marrow transplants carry risks, such as side effects from the medicines, infections, and the possibility of the body rejecting the new cells. There's also a chance the transplant may not work. You have the right to withdraw your child from the study at any time without affecting their regular medical care.

Standorte (15)

  • Children's Hospital of Alabama
    Verifizierte Postleitzahl
    Birmingham, Vereinigte Staaten
  • Phoenix Children's
    Verifizierte Postleitzahl
    Phoenix, Vereinigte Staaten
  • Yale University, Yale Cancer Center
    Verifizierte Postleitzahl
    New Haven, Vereinigte Staaten
  • Nationales Kinderkrankenhaus
    Verifizierte Postleitzahl
    Washington D.C., Vereinigte Staaten
  • Children's Healthcare of Altanta
    Verifizierte Postleitzahl
    Atlanta, Vereinigte Staaten
  • Universität von Chicago
    Verifizierte Postleitzahl
    Chicago, Vereinigte Staaten
  • Riley Children's Health/Indiana University
    Verifizierte Postleitzahl
    Indianapolis, Vereinigte Staaten
  • Dana-Farber Cancer Institute/Boston Children's Hospital
    Verifizierte Postleitzahl
    Boston, Vereinigte Staaten
  • Washington University School of Medicine
    Verifizierte Postleitzahl
    St. Louis, Vereinigte Staaten
  • Hackensack Universitätsklinikum
    Verifizierte Postleitzahl
    Hackensack, Vereinigte Staaten
  • University of North Carolina Medical Center
    Verifizierte Postleitzahl
    Chapel Hill, United States
  • Atrium Health Levine Cancer Institute
    Verifizierte Postleitzahl
    Charlotte, Vereinigte Staaten

Häufige Fragen

Was ist Sichelzellenanämie?

Sickle cell disease is an inherited blood condition where red blood cells are shaped like a 'C' or sickle. These cells can block blood flow, causing pain and other serious problems.

What is a bone marrow transplant?

A bone marrow transplant replaces unhealthy blood-forming cells in your child's body with healthy cells from a donor. In this study, the donor is a healthy brother or sister.

What are 'conditioning medicines'?

These are special medicines, including chemotherapy, given before the transplant to prepare your child's body to accept the new healthy cells and prevent them from rejecting the donor's cells.

How long will my child be in the hospital?

Your child will be in the hospital for about three weeks before the transplant and then for another 4 to 6 weeks after the transplant.

Will my child still need check-ups after the study ends?

Yes, even after the study collects data for two years, your child will continue to have yearly check-ups for many years by doctors who understand sickle cell and transplants.

Wie Sie mehr erfahren können

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.